Apellis Pharmaceuticals Inc (APLS)
48.00
-3.88
(-7.48%)
USD |
NASDAQ |
Apr 17, 16:00
48.00
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Price: 48.00 for April 17, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 16, 2024 | 51.40 | 53.06 | 50.70 | 51.88 | 899126.0 |
| Apr 15, 2024 | 51.76 | 53.04 | 50.28 | 51.50 | 2.616M |
| Apr 12, 2024 | 55.13 | 55.60 | 50.07 | 51.79 | 2.003M |
| Apr 11, 2024 | 57.15 | 57.85 | 55.22 | 55.73 | 1.054M |
| Apr 10, 2024 | 53.71 | 57.03 | 53.71 | 56.84 | 780445.0 |
| Apr 09, 2024 | 53.77 | 55.33 | 53.45 | 55.12 | 852427.0 |
| Apr 08, 2024 | 55.99 | 55.99 | 53.76 | 53.81 | 809179.0 |
| Apr 05, 2024 | 55.60 | 56.13 | 54.44 | 55.91 | 695017.0 |
| Apr 04, 2024 | 56.95 | 58.12 | 55.90 | 56.05 | 763078.0 |
| Apr 03, 2024 | 55.40 | 57.49 | 55.12 | 56.95 | 1.080M |
| Apr 02, 2024 | 58.51 | 58.51 | 54.42 | 55.70 | 1.165M |
| Apr 01, 2024 | 58.66 | 59.91 | 57.56 | 59.71 | 963661.0 |
| Mar 28, 2024 | 58.47 | 58.96 | 56.82 | 58.78 | 1.253M |
| Mar 27, 2024 | 59.36 | 59.36 | 57.64 | 58.49 | 1.035M |
| Mar 26, 2024 | 56.32 | 59.07 | 55.88 | 59.00 | 1.219M |
| Mar 25, 2024 | 55.36 | 56.72 | 55.08 | 55.53 | 738337.0 |
| Mar 22, 2024 | 57.00 | 57.00 | 55.21 | 55.39 | 995035.0 |
| Mar 21, 2024 | 56.00 | 57.29 | 55.60 | 56.61 | 1.170M |
| Mar 20, 2024 | 56.34 | 56.34 | 53.19 | 55.52 | 1.560M |
| Mar 19, 2024 | 55.75 | 57.70 | 55.56 | 56.92 | 1.083M |
| Mar 18, 2024 | 57.06 | 57.48 | 55.97 | 56.26 | 975408.0 |
| Mar 15, 2024 | 55.99 | 57.04 | 55.45 | 56.74 | 1.057M |
| Mar 14, 2024 | 57.07 | 57.17 | 55.17 | 56.48 | 1.557M |
| Mar 13, 2024 | 58.56 | 59.54 | 56.86 | 57.36 | 1.133M |
| Mar 12, 2024 | 60.64 | 60.64 | 57.82 | 58.50 | 1.636M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
17.91
Minimum
Mar 17 2020
93.31
Maximum
Jun 13 2023
45.98
Average
44.96
Median
Price Benchmarks
| Sarepta Therapeutics Inc | 117.81 |
| Blueprint Medicines Corp | 88.38 |
| Alnylam Pharmaceuticals Inc | 145.31 |
| Ionis Pharmaceuticals Inc | 40.91 |
| Madrigal Pharmaceuticals Inc | 228.67 |
Price Related Metrics
| PS Ratio | 14.36 |
| Price to Book Value | 29.75 |
| Earnings Yield | -9.33% |
| Market Cap | 5.788B |